{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:45Z","timestamp":1792182345788,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.psyneuen.2016.07.209","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T06:56:33Z","timestamp":1468738593000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["\u03b2-hydroxybutyrate, pyruvate and metabolic profiles in patients with schizophrenia: A case control study"],"prefix":"10.1016","volume":"73","author":[{"given":"Yu-Chi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Fa","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian-Yoon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2016.07.209_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative v positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0015","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00004647-200110000-00001","article-title":"An energy budget for signaling in the grey matter of the brain","volume":"21","author":"Attwell","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0025","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.euroneuro.2015.06.011","article-title":"Second-generation antipsychotics and adiponectin levels in schizophrenia: a comparative meta-analysis","volume":"25","author":"Bartoli","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","article-title":"Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis","volume":"56","author":"Bartoli","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"Belanger","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1022498714522","article-title":"Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield","volume":"29","author":"Brand","year":"1997","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/oxfordjournals.schbul.a033331","article-title":"Positron emission tomography studies of abnormal glucose metabolism in schizophrenia","volume":"24","author":"Buchsbaum","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","article-title":"Fuel metabolism in starvation","volume":"26","author":"Cahill","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0055","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/j.1440-1614.2004.01364.x","article-title":"Quality of life and related risk factors in a Taiwanese village population 21 months after an earthquake","volume":"38","author":"Chou","year":"2004","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.genhosppsych.2014.08.005","article-title":"Cardiovascular risk factors among people with severe mental illness in Italy: a cross-sectional comparative study","volume":"36","author":"Clerici","year":"2014","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphys.2014.00260","article-title":"Role of beta-hydroxybutyrate, its polymer poly-beta-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease","volume":"5","author":"Dedkova","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0075","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","article-title":"Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique","volume":"31","author":"Fatemi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.plefa.2003.11.001","article-title":"Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry","volume":"70","author":"Fukao","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0085","doi-asserted-by":"crossref","first-page":"e101652","DOI":"10.1371\/journal.pone.0101652","article-title":"Quantitative analyses of schizophrenia-associated metabolites in serum: serum d-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients","volume":"9","author":"Fukushima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1043-2760(00)00370-2","article-title":"Is there an astrocyte-neuron ketone body shuttle?","volume":"12","author":"Guzman","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics: differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS drugs"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0100","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","article-title":"Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia","volume":"3","author":"Holmes","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1172\/JCI1009","article-title":"Beta-hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices","volume":"101","author":"Izumi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0278-5846(90)90016-A","article-title":"Measurement of plasma homovanillic acid concentrations in schizophrenic patients","volume":"14","author":"Kaminski","year":"1990","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0120","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"d-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0135","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0024-3205(91)90438-H","article-title":"The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients","volume":"48","author":"Konicki","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.ps.54.2.249","article-title":"Prevalence of psychiatric disorders among bereaved survivors of a disastrous earthquake in taiwan","volume":"54","author":"Kuo","year":"2003","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0150","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1038\/tp.2015.213","article-title":"Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue","volume":"6","author":"Lai","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-1-11","article-title":"Schizophrenia proteomics: biomarkers on the path to laboratory medicine?","volume":"1","author":"Lakhan","year":"2006","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12967-015-0540-y","article-title":"Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study","volume":"13","author":"Liu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0148607194018003208","article-title":"Effects of the short-chain triglyceride triacetin on intestinal mucosa and metabolic substrates in rats","volume":"18","author":"Lynch","year":"1994","journal-title":"JPEN. J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12445","article-title":"Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management","volume":"132","author":"Manu","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0180","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2015_399","article-title":"Pathological implications of oxidative stress in patients and animal models with schizophrenia: the role of epidermal growth factor receptor signaling","author":"Nagano","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0185","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.jcp.0000142282.62336.e9","article-title":"Atypical antipsychotics and metabolic dysregulation: evaluating the risk\/benefit equation and improving the standard of care","volume":"24","author":"Nasrallah","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0190","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI105650","article-title":"Brain metabolism during fasting","volume":"46","author":"Owen","year":"1967","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0195","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2011.04.017","article-title":"The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia","volume":"191","author":"Ritsner","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0215","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 20","key":"10.1016\/j.psyneuen.2016.07.209_bib0220","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0225","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0230","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00125-008-1152-3","article-title":"Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat","volume":"51","author":"Smith","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.schres.2013.07.044","article-title":"Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight","volume":"150","author":"Song","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0240","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0245","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2016. http:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0250","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0255","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj1210041","article-title":"Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues","volume":"121","author":"Williamson","year":"1971","journal-title":"Biochem. J"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","article-title":"The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls","volume":"150","author":"Wu","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0270","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.psyneuen.2015.09.005","article-title":"Glucose disturbances in first-episode drug-naive schizophrenia: relationship to psychopathology","volume":"62","author":"Zhang","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.07.209_bib0275","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jnc.12127","article-title":"Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease","volume":"125","author":"Zilberter","year":"2013","journal-title":"J. Neurochem."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016304401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016304401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:53:12Z","timestamp":1759683192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016304401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":55,"alternative-id":["S0306453016304401"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.209","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-hydroxybutyrate, pyruvate and metabolic profiles in patients with schizophrenia: A case control study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}